Literature DB >> 3556219

Immunoblotting and ligand blotting of the low-density lipoprotein receptor of human liver, HepG2 cells and HeLa cells.

J R Havinga, P Lohse, U Beisiegel.   

Abstract

Low-density lipoprotein receptors from adult human liver and the human hepatoblastoma cell line HepG2 were analyzed by polyacrylamide electrophoresis in SDS followed by immuno- and ligand blotting. In both liver and HepG2 we detected a protein band with apparent relative molecular mass of 130 kDa, which is similar to that of the LDL receptor in fibroblasts. In addition we showed that HeLa cells also possess this LDL-receptor protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556219     DOI: 10.1016/0014-5793(87)80705-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Uptake and degradation of human low-density lipoprotein by human liver parenchymal and Kupffer cells in culture.

Authors:  J A Kamps; J K Kruijt; J Kuiper; T J Van Berkel
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo.

Authors:  M J Rudling; E Reihnér; K Einarsson; S Ewerth; B Angelin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

3.  Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells.

Authors:  B J McKeone; J R Patsch; H J Pownall
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

4.  Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu).

Authors:  W A Mann; P Lohse; R E Gregg; R Ronan; J M Hoeg; L A Zech; H B Brewer
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.